Biocartis is a privately owned biotech company that engages in the development of novel diagnostics technology platforms for low to highly multiplexed detection of molecular-based biomarkers. Biocartis is based at the EPFL Science Park in Lausanne (Switzerland), at the High Tech Campus in Eindhoven (The Netherlands) and is setting up a manufacturing and assay development facility in Mechelen (Belgium).